The evidence of the beneficial effects of dairy products on the intestinal microflora was given for the first time in 1908 by I.I. Mechnikov in the famous article «A few words about the sour milk». Since that time probiotics - the living microorganisms for regulation of intestinal microbiota are the case of interest. Interactions between the probiotics and macroorganism are very complex and include a network of genes receptors, signaling molecules and a variety of other factors that determine the natural course of the disease.

Asthma is a common chronic respiratory disease, characterized by different mechanisms and the development of heterogeneous phenotypes. This review discusses the main pharmacotherapy innovations and their possible clinical application.